Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
Gespeichert in:
Veröffentlicht in: | International journal of geriatric psychiatry 2008-09, Vol.23 (9), p.979-981 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 981 |
---|---|
container_issue | 9 |
container_start_page | 979 |
container_title | International journal of geriatric psychiatry |
container_volume | 23 |
creator | Waldemar, Gunhild Hyvärinen, Maritta Josiassen, Mette Krog Kørner, Alex Lehto, Heikki Wetterberg, Peter |
description | |
doi_str_mv | 10.1002/gps.1979 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21143327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21143327</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4439-a5f2779b8c18265cccfa549c8eff143785b6ec9cbd9a162cfcd284b3500ec4b23</originalsourceid><addsrcrecordid>eNp10F1vFCEUBmBiNHZbTfwFhhutN1OB-QAum6bdaprWxPXjjjDMoYvODCOwrttfL5ud1CuvIOE57yEvQq8oOaOEsPf3UzyjkssnaEGJlAWlTfMULYgQddGwkhyh4xh_EJLfqHiOjqhgTApeLdB25XsIunW9SzvsLY5bl8zajffYBj_gzo8wwYPrcfJ4gEGPyY2AUwCdBhgTdiOedHL5GnEeXePBdzkwwX4gwm8IgM_7hzW4AcJpxJ2LoCO8QM-s7iO8nM8T9OXqcnVxXdzcLT9cnN8UpqpKWejaMs5lK0z-clMbY6yuK2kEWEurkou6bcBI03ZS04YZazomqrasCQFTtaw8QW8PuVPwvzYQkxpcNND3egS_iYrRHFMynuG7AzTBxxjAqim4QYedokTtS1a5ZLUvOdPXc-amHaD7B-dWM3gzAx2N7m3Qo3Hx0THSUMHpPqg4uK3rYfffhWr56fO8ePYuJvjz6HX4qRpe8lp9u12q64-r7yXhK_W1_Avl8qUY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21143327</pqid></control><display><type>article</type><title>Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Waldemar, Gunhild ; Hyvärinen, Maritta ; Josiassen, Mette Krog ; Kørner, Alex ; Lehto, Heikki ; Wetterberg, Peter</creator><creatorcontrib>Waldemar, Gunhild ; Hyvärinen, Maritta ; Josiassen, Mette Krog ; Kørner, Alex ; Lehto, Heikki ; Wetterberg, Peter</creatorcontrib><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.1979</identifier><identifier>PMID: 18229874</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Aged ; Aged, 80 and over ; Alzheimer Disease - diagnosis ; Alzheimer Disease - drug therapy ; Biological and medical sciences ; Cholinesterase Inhibitors - adverse effects ; Cholinesterase Inhibitors - therapeutic use ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dopamine Agents - adverse effects ; Dopamine Agents - therapeutic use ; Double-Blind Method ; Female ; Fundamental and applied biological sciences. Psychology ; Geriatrics ; Humans ; Indans - adverse effects ; Indans - therapeutic use ; Male ; Medical sciences ; Memantine - adverse effects ; Memantine - therapeutic use ; Neurology ; Piperidines - adverse effects ; Piperidines - therapeutic use ; Psychoanalysis ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Severity of Illness Index</subject><ispartof>International journal of geriatric psychiatry, 2008-09, Vol.23 (9), p.979-981</ispartof><rights>Copyright © 2008 John Wiley & Sons, Ltd.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4439-a5f2779b8c18265cccfa549c8eff143785b6ec9cbd9a162cfcd284b3500ec4b23</citedby><cites>FETCH-LOGICAL-c4439-a5f2779b8c18265cccfa549c8eff143785b6ec9cbd9a162cfcd284b3500ec4b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fgps.1979$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fgps.1979$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20618719$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18229874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waldemar, Gunhild</creatorcontrib><creatorcontrib>Hyvärinen, Maritta</creatorcontrib><creatorcontrib>Josiassen, Mette Krog</creatorcontrib><creatorcontrib>Kørner, Alex</creatorcontrib><creatorcontrib>Lehto, Heikki</creatorcontrib><creatorcontrib>Wetterberg, Peter</creatorcontrib><title>Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease</title><title>International journal of geriatric psychiatry</title><addtitle>Int. J. Geriat. Psychiatry</addtitle><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Cholinesterase Inhibitors - adverse effects</subject><subject>Cholinesterase Inhibitors - therapeutic use</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dopamine Agents - adverse effects</subject><subject>Dopamine Agents - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Geriatrics</subject><subject>Humans</subject><subject>Indans - adverse effects</subject><subject>Indans - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memantine - adverse effects</subject><subject>Memantine - therapeutic use</subject><subject>Neurology</subject><subject>Piperidines - adverse effects</subject><subject>Piperidines - therapeutic use</subject><subject>Psychoanalysis</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Severity of Illness Index</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10F1vFCEUBmBiNHZbTfwFhhutN1OB-QAum6bdaprWxPXjjjDMoYvODCOwrttfL5ud1CuvIOE57yEvQq8oOaOEsPf3UzyjkssnaEGJlAWlTfMULYgQddGwkhyh4xh_EJLfqHiOjqhgTApeLdB25XsIunW9SzvsLY5bl8zajffYBj_gzo8wwYPrcfJ4gEGPyY2AUwCdBhgTdiOedHL5GnEeXePBdzkwwX4gwm8IgM_7hzW4AcJpxJ2LoCO8QM-s7iO8nM8T9OXqcnVxXdzcLT9cnN8UpqpKWejaMs5lK0z-clMbY6yuK2kEWEurkou6bcBI03ZS04YZazomqrasCQFTtaw8QW8PuVPwvzYQkxpcNND3egS_iYrRHFMynuG7AzTBxxjAqim4QYedokTtS1a5ZLUvOdPXc-amHaD7B-dWM3gzAx2N7m3Qo3Hx0THSUMHpPqg4uK3rYfffhWr56fO8ePYuJvjz6HX4qRpe8lp9u12q64-r7yXhK_W1_Avl8qUY</recordid><startdate>200809</startdate><enddate>200809</enddate><creator>Waldemar, Gunhild</creator><creator>Hyvärinen, Maritta</creator><creator>Josiassen, Mette Krog</creator><creator>Kørner, Alex</creator><creator>Lehto, Heikki</creator><creator>Wetterberg, Peter</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200809</creationdate><title>Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease</title><author>Waldemar, Gunhild ; Hyvärinen, Maritta ; Josiassen, Mette Krog ; Kørner, Alex ; Lehto, Heikki ; Wetterberg, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4439-a5f2779b8c18265cccfa549c8eff143785b6ec9cbd9a162cfcd284b3500ec4b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Cholinesterase Inhibitors - adverse effects</topic><topic>Cholinesterase Inhibitors - therapeutic use</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dopamine Agents - adverse effects</topic><topic>Dopamine Agents - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Geriatrics</topic><topic>Humans</topic><topic>Indans - adverse effects</topic><topic>Indans - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memantine - adverse effects</topic><topic>Memantine - therapeutic use</topic><topic>Neurology</topic><topic>Piperidines - adverse effects</topic><topic>Piperidines - therapeutic use</topic><topic>Psychoanalysis</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waldemar, Gunhild</creatorcontrib><creatorcontrib>Hyvärinen, Maritta</creatorcontrib><creatorcontrib>Josiassen, Mette Krog</creatorcontrib><creatorcontrib>Kørner, Alex</creatorcontrib><creatorcontrib>Lehto, Heikki</creatorcontrib><creatorcontrib>Wetterberg, Peter</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waldemar, Gunhild</au><au>Hyvärinen, Maritta</au><au>Josiassen, Mette Krog</au><au>Kørner, Alex</au><au>Lehto, Heikki</au><au>Wetterberg, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int. J. Geriat. Psychiatry</addtitle><date>2008-09</date><risdate>2008</risdate><volume>23</volume><issue>9</issue><spage>979</spage><epage>981</epage><pages>979-981</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>18229874</pmid><doi>10.1002/gps.1979</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-6230 |
ispartof | International journal of geriatric psychiatry, 2008-09, Vol.23 (9), p.979-981 |
issn | 0885-6230 1099-1166 |
language | eng |
recordid | cdi_proquest_miscellaneous_21143327 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Aged Aged, 80 and over Alzheimer Disease - diagnosis Alzheimer Disease - drug therapy Biological and medical sciences Cholinesterase Inhibitors - adverse effects Cholinesterase Inhibitors - therapeutic use Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dopamine Agents - adverse effects Dopamine Agents - therapeutic use Double-Blind Method Female Fundamental and applied biological sciences. Psychology Geriatrics Humans Indans - adverse effects Indans - therapeutic use Male Medical sciences Memantine - adverse effects Memantine - therapeutic use Neurology Piperidines - adverse effects Piperidines - therapeutic use Psychoanalysis Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Severity of Illness Index |
title | Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A50%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tolerability%20of%20switching%20from%20donepezil%20to%20memantine%20treatment%20in%20patients%20with%20moderate%20to%20severe%20Alzheimer's%20disease&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Waldemar,%20Gunhild&rft.date=2008-09&rft.volume=23&rft.issue=9&rft.spage=979&rft.epage=981&rft.pages=979-981&rft.issn=0885-6230&rft.eissn=1099-1166&rft_id=info:doi/10.1002/gps.1979&rft_dat=%3Cproquest_cross%3E21143327%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21143327&rft_id=info:pmid/18229874&rfr_iscdi=true |